APA

Casanova A. G., Vicente-Vicente L., Hernández-Sánchez M. T., Prieto M., Rihuete M. I., Ramis L. M., Del Barco E., Cruz J. J., Ortiz A., Cruz-González I., Martínez-Salgado C., Pescador M., López-Hernández F. J. & Morales A. I. (20200602). Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chicago

Casanova Alfredo G, Vicente-Vicente Laura, Hernández-Sánchez M Teresa, Prieto Marta, Rihuete M Isabel, Ramis Laura M, Del Barco Elvira, Cruz Juan J, Ortiz Alberto, Cruz-González Ignacio, Martínez-Salgado Carlos, Pescador Moisés, López-Hernández Francisco J and Morales Ana I. 20200602. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Harvard

Casanova A. G., Vicente-Vicente L., Hernández-Sánchez M. T., Prieto M., Rihuete M. I., Ramis L. M., Del Barco E., Cruz J. J., Ortiz A., Cruz-González I., Martínez-Salgado C., Pescador M., López-Hernández F. J. and Morales A. I. (20200602). Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MLA

Casanova Alfredo G, Vicente-Vicente Laura, Hernández-Sánchez M Teresa, Prieto Marta, Rihuete M Isabel, Ramis Laura M, Del Barco Elvira, Cruz Juan J, Ortiz Alberto, Cruz-González Ignacio, Martínez-Salgado Carlos, Pescador Moisés, López-Hernández Francisco J and Morales Ana I. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20200602.